Daybue Stix 8000 MG Powder for Oral Solution
- RxCUI
- 2729459
- RxNorm name
- Daybue Stix 8000 MG Powder for Oral Solution
- Display name
- Daybue Stix 8000 MG Powder for Oral Solution
- Full name
- Daybue Stix 8000 MG Powder for Oral Solution
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Daybue | TROFINETIDE | Acadia Pharmaceuticals Inc. | 67e6f2d9-21f6-466f-9def-826c6a4b8257 | 2026-09-04 | Warnings, Adverse reactions | 2729459 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 67e6f2d9-21f6-466f-9def-826c6a4b8257 | Daybue Stix 8000 MG Powder for Oral Solution [PSN] · trofinetide 8000 MG Powder for Oral Solution [Daybue] [SBD] · Daybue 8000 MG Powder for Oral Solution [SY] | 3 | 10 | These highlights do not include all the information needed to use DAYBUE or DAYBUE STIX safely and effectively. See full prescribing information for DAYBUE and DAYBUE STIX. DAYBUE ® (trofinetide) oral solution DAYBUE ® STIX (trofinetide) for oral solution Initial U.S. Approval: 2023 | 20260403 |